Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISPAT-3D: Spatially Varying Conditional Volumetric Network Estimation for 3D Tumor Imaging.

Research square·2026
Same author

Promise and pragmatism of AI in global-scale digital pathology: pan-cancer approaches for clinical practice.

Journal of clinical pathology·2026
Same author

TAZ mediates enhancer reprogramming blocks neuronal differentiation in glioma stem-like cells.

Scientific reports·2026
Same author

Health system learning enables generalist neuroimaging models.

Nature medicine·2026
Same author

The lipedema common case report form as a research tool: standardizing lipedema data collection.

Frontiers in global women's health·2026
Same author

A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Nov 29, 2025

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.5K

Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data

Joonsang Lee1, Nicholas Wang1, Sevcan Turk2

  • 1Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Scientific Reports
|November 24, 2020
PubMed
Summary

Distinguishing pseudoprogression from true tumor progression in diffuse infiltrating gliomas is crucial. A deep learning model using multiparametric MRI sequences effectively improved diagnostic accuracy for this challenge.

More Related Videos

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.4K
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
06:48

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

Published on: January 7, 2019

9.2K

Related Experiment Videos

Last Updated: Nov 29, 2025

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.5K
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.4K
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
06:48

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

Published on: January 7, 2019

9.2K

Area of Science:

  • Neuro-oncology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Differentiating pseudoprogression from true tumor progression in diffuse infiltrating gliomas, especially high-grade gliomas, presents a significant clinical challenge.
  • This distinction is critical for timely treatment initiation in patients experiencing glioma recurrence, as delays can negatively impact outcomes.

Purpose of the Study:

  • To develop and evaluate a deep learning model for discriminating between pseudoprogression and true tumor progression in diffuse infiltrating gliomas.
  • To assess the efficacy of using multiparametric MRI sequences as input for a convolutional neural network-recurrent neural network (CNN-LSTM) structure.

Main Methods:

  • A dataset of 43 biopsy-proven diffuse infiltrating glioma patients with disease progression or recurrence was utilized.
  • Five original MRI sequences (T1-weighted pre- and post-contrast, T2-weighted, FLAIR, ADC) and two engineered sequences were processed.
  • Three CNN-LSTM models with varying input sequence combinations were trained and evaluated using threefold cross-validation.

Main Results:

  • The CNN-LSTM models achieved higher diagnostic performance compared to VGG16 models, with mean accuracies ranging from 0.62 to 0.75 and mean AUCs from 0.64 to 0.81.
  • The proposed CNN-LSTM approach using multiparametric MRI sequences outperformed traditional convolutional neural networks (CNNs) utilizing single MRI sequences.
  • Incorporating all available MRI sequences into the CNN-LSTM model significantly improved the diagnostic performance for distinguishing pseudoprogression from true tumor progression.

Conclusions:

  • Multiparametric MRI data, when processed through a CNN-LSTM deep learning architecture, offers a promising method for accurately differentiating pseudoprogression from true tumor progression in diffuse infiltrating gliomas.
  • This advanced imaging analysis approach has the potential to reduce treatment delays and improve patient management for glioma recurrence.